C.L. de Winter

<i>In vivo</i> comparison of 2′‐<i>O</i>‐methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping

Hans Heemskerk, C.L. de Winter, Sjef J. de Kimpe et al. · The Journal of Gene Medicine · 2009 · 169 citations · Full text

Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms

Annemieke Aartsma‐Rus, Laura Van de Vliet, Marscha Hirschi et al. · Molecular Therapy · 2008 · 145 citations · Full text

Functional Analysis of 114 Exon-Internal AONs for Targeted DMD Exon Skipping: Indication for Steric Hindrance of SR Protein Binding Sites

Annemieke Aartsma‐Rus, C.L. de Winter, Anneke A. M. Janson et al. · Oligonucleotides · 2005 · 105 citations

Exon-internal Aons, Molecular Biology, Functional Analysis +16

Assessment of the feasibility of exon 45–55 multiexon skipping for duchenne muscular dystrophy

Laura Van de Vliet, C.L. de Winter, Judith CT van Deutekom et al. · BMC Medical Genetics · 2008 · 53 citations · Full text

Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials

Linda Popplewell, C. Adkin, Virginia Arechavala‐Gomeza et al. · Neuromuscular Disorders · 2010 · 44 citations

Novel Therapy, Immunology, Oligonucleotide +8